REGULARIZATION OF UNOPS EXPENSES

This tender, initiated by the Guatemalan Social Security Institute (IGSS), concerns the regularization of expenses related to UNOPS (United Nations Office for Project Services). The primary item listed for this regularization is Indapamide. The procurement method specified is Regulated Procedures under Article 44 of the LCE (Cases of Exception), indicating a non-standard procurement process often used in specific, justified circumstances. The tender is currently in a 'Not Awarded' status, meaning no contract has yet been finalized. This implies that the process is ongoing or has been halted before a successful bidder was selected. The context suggests a need to formally account for or settle expenditures previously managed or incurred under the purview of UNOPS, with Indapamide being a specific component of these expenses. Further details regarding the exact nature of the expenses, the value of the contract, or the specific reasons for invoking Article 44 of the LCE are not provided in this summary. However, the involvement of IGSS and UNOPS points towards a public sector initiative likely related to healthcare or social services, where Indapamide, a diuretic medication, would be relevant. The exceptional procurement procedure highlights the unique conditions under which this tender is being conducted.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals. Located in Guatemala, Latin America, this opportunity is open to firms and consortiums.

Published through Guatecompras, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.